Jonathan E. Lim

2009 - Halozyme Therapeutics

In 2009, Jonathan E. Lim earned a total compensation of $837K as Former President and Chief Executive Officer at Halozyme Therapeutics, a 55% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$12,063
Option Awards$422,268
Salary$395,000
Other$7,717
Total$837,048

Lim received $422.3K in option awards, accounting for 50% of the total pay in 2009.

Lim also received $12.1K in non-equity incentive plan, $395K in salary and $7.7K in other compensation.

Rankings

In 2009, Jonathan E. Lim's compensation ranked 5,051st out of 9,885 executives tracked by ExecPay. In other words, Lim earned more than 48.9% of executives.

ClassificationRankingPercentile
All
5,051
out of 9,885
49th
Division
Manufacturing
1,810
out of 3,690
51st
Major group
Chemicals And Allied Products
372
out of 871
57th
Industry group
Drugs
233
out of 643
64th
Industry
Biological Products, Except Diagnostic Substances
43
out of 138
69th
Source: SEC filing on March 24, 2011.

Lim's colleagues

We found eight more compensation records of executives who worked with Jonathan E. Lim at Halozyme Therapeutics in 2009.

2009

Jonathan Leff

Halozyme Therapeutics

Chief Medical Officer

2009

Kurt Gustafson

Halozyme Therapeutics

Chief Financial Officer

2009

H Shepard

Halozyme Therapeutics

Chief Scientific Officer

2009

Gregory Frost

Halozyme Therapeutics

Chief Executive Officer

2009

William Fallon

Halozyme Therapeutics

Vice President, Manufacturing & Operations

2009

David Ramsay

Halozyme Therapeutics

Vice President Corporate Development

2009

Robert Little

Halozyme Therapeutics

Vice President and Chief Commercial Officer

2009

Michael LaBarre

Halozyme Therapeutics

Vice President, Product Development

News

In-depth

You may also like